Étiquette : expérience mystique

Ayahuasca Scientific Papers, AEDMP, 2013

Ayahuasca Scientific Papers AEDMP - Asociación para el Estudio y la Divulgación de la Medicina Psicodélica Research conducted by: Genís Oña -2013- Asociación para el Estudio y la Divulgación de la Medicina Psicodélica. Castellarnau, 11 2º 1ª 43004 Tarragona Spain Tel. 675 55 33 44 Email: medicina.psicodelica@hotmail.com www.medicinapsicodelica.org   Content _____________________________________ 1. What is ayahuasca? 2. Scientific papers about ayahuasca arranged chronologically (1969-2013) - G. R. Dolmatoff (1969). El contexto cultural de un alucinógeno aborigen : Banisteriopsis Caapi - C. Grob et al. (1996). Human Psychopharmacology of Hoasca, a Plant Hallucinogen Used in Ritual Context in Brazil - J. C. Callaway et al. (1999). Pharmacokinetics of Hoasca Alkaloids in Healthy Humans - B. Shanon (2000). Ayahuasca and [...]

Lire la suite

The Psychedelic Library – Bibliographie

http://psychedelic-library.org/lsdmenu.htm   Alas! the forbidden fruits were eaten, And thereby the warm life of reason congealed. A grain of wheat eclipsed the sun of Adam, Like as the Dragon's tail dulls the brightness of the moon. — Rumi: Masnavi I Ma'navi   Introductory Papers The Exploration of Experience by: Humphrey Osmond, an excerpt from his 1957 paper "A Review of the Clinical Effects of Psychotomimetic Agents" Psychedelics, Technology, Psychedelics by: Bernard Aaronson and Humphry Osmond, the introductory chapter to PSYCHEDELICS, the Uses and Implications of Hallucinogenic Drugs Psychedelics and the Future by Humphry Osmond and Bernard S. Aaronson Request for a Public Hearing to: The Hearing Clerk, Department of Health, Education and Welfare   Menus Psychotherapy and Psychedelic Drugs Psychedelic Research [...]

Lire la suite

The Secret of the Kykeon, Peter Webster

The Secret of the Kykeon Peter Webster The Psychedelic Library   The original hypothesis of The Road to Eleusis suggests that the ergot species Claviceps purpurea, collected by the hierophantic priests from its natural and common parasitisation on barley growing in the Rarian plain adjacent to Eleusis, was the probable active ingredient of the kykeon, the psychoactive potion used in the yearly Rite at Eleusis. It was further suggested that the hierophants would have processed the C. purpurea ergot by dissolving off the water-soluble alkaloids since this fraction contained ergonovine, the principal hypothesised psychoactive compound, a lysergic acid amide very similar in structure to, [...]

Lire la suite

Pharmacology of Consciousness or Pharmacology of Spirituality ? A Historical Review of Psychedelic Clinical Studies, Ismael Apud, 2016

Pharmacology of Consciousness or Pharmacology of Spirituality ? A Historical Review of Psychedelic Clinical Studies Ismael Apud The Journal of Transpersonal Psychology, 2016, Vol. 48, No. 2, 150-167.   ABSTRACT: In the second half of the twentieth century, when psychopharmacology was not developed as we know it today and psychoanalysis was an influential school, various psychiatrists began to develop a ‘pharmacology of consciousness,’ and became interested in hallucinogens as new paths for accessing the unconscious. However, with the psychedelic model, the pharmacology of consciousness turned also into a ‘pharmacology of spirituality,’ focused on the use of spiritual experiences as catalyzers of psychological change. This article [...]

Lire la suite

Powerful substances in tiny amounts: Exploring the practice of microdosing psychedelic drugs, Petter Grahl Johnstad, 2017

Powerful substances in tiny amounts: Exploring the practice of microdosing psychedelic drugs Petter Grahl Johnstad Working Paper · December 2017 Nordic Studies on Alcohol and Drugs, 2018, Vol. 35(1) 39–51. Doi : 10.1177/1455072517753339   This article presents an explorative study of microdosing practices with psychedelic drugs. A microdose is defined as a sub-perceptual dose, commonly about one tenth of an ordinary recreational dose, which gives no alteration of consciousness or feeling of intoxication. Respondents (n = 17) were recruited at several Internet fora for individual interviews mediated via private messaging. Every participant was male, and the median respondent was in his 30s with a stable job [...]

Lire la suite

Psychedelic Induced Transpersonal Experiences, Therapies, and Their Implications for Transpersonal Psychology, Thomas B. Roberts and Michael J. Winkelman, 2013

Psychedelic Induced Transpersonal Experiences, Therapies, and Their Implications for Transpersonal Psychology Thomas B. Roberts and Michael J. Winkelman Chapter 25 - The Wiley-Blackwell Handbook of Transpersonal Psychology, First Edition. Edited by Harris L. Friedman and Glenn Hartelius. © 2013 John Wiley & Sons, Ltd. Published 2013 by John Wiley & Sons, Ltd.   Psychedelics and other natural and synthetic substances have an ability to induce a range of transpersonal experiences. The predominance of spiritually-related experiences from these substances has led to the development of the concept of entheogen— reflecting their potential to produce an internal experience of communing with god. The similarity of the drug-induced transpersonal [...]

Lire la suite

Cultural Neurophenomenology of Psychedelic Thought : Guiding the “Unconstrained” Mind Through Ritual Context, Michael Lifshitz et al., 2018

Cultural Neurophenomenology of Psychedelic Thought : Guiding the “Unconstrained” Mind Through Ritual Context Michael Lifshitz, Eli Sheiner, and Laurence J. Kirmayer The Oxford Handbook of Spontaneous Thought : Mind-Wandering, Creativity, and Dreaming, Edited by Kalina Christoff and Kieran C.R. Fox May 2018 DOI: 10.1093/oxfordhb/9780190464745.013.4   Abstract This chapter explores psychedelics as catalysts of spontaneous thought. Classic serotonergic psychedelics such as psilocybin, LSD, and ayahuasca can induce potent alterations in cognition and perception. The chapter reviews research on these substances through the lens of cultural neurophenomenology, which aims to trace how neurobiology and sociocultural factors interact to shape experience. After a decades-long hiatus, the scientific study of psychedelics [...]

Lire la suite

Classic Hallucinogens and Mystical Experiences : Phenomenology and Neural Correlates, Frederick S. Barrett and Roland R. Griffiths, 2017

Classic Hallucinogens and Mystical Experiences : Phenomenology and Neural Correlates Frederick S. Barrett and Roland R. Griffiths The following chapter will appear in the Springer text “Behavioral Neurobiology of Psychedelic Drugs”, in the series “Current Topics in Behavioral Neuroscience” that is edited by Adam L Halberstadt, Franz X Vollenweider, and David E Nichols Current Topics in Behavioral Neuroscience, 2017 March 26. DOI: 10.1007/7854_2017_474   Abstract This chapter begins with a brief review of descriptions and definitions of mystical-type experiences and the historical connection between classic hallucinogens and mystical experiences. The chapter then explores the empirical literature on experiences with classic hallucinogens in which claims about mystical or religious experiences [...]

Lire la suite

The Mechanisms of Psychedelic Visionary Experiences : Hypotheses from Evolutionary Psychology, Michael J. Winkelman, 2017

The Mechanisms of Psychedelic Visionary Experiences: Hypotheses from Evolutionary Psychology Michael J. Winkelman Frontiers in Neuroscience, 2017, 11, article 539, 1-17. doi: 10.3389/fnins.2017.00539   Neuropharmacological effects of psychedelics have profound cognitive, emotional, and social effects that inspired the development of cultures and religions worldwide. Findings that psychedelics objectively and reliably produce mystical experiences press the question of the neuropharmacological mechanisms by which these highly significant experiences are produced by exogenous neurotransmitter analogs. Humans have a long evolutionary relationship with psychedelics, a consequence of psychedelics’ selective effects for human cognitive abilities, exemplified in the information rich visionary experiences. Objective evidence that psychedelics produce classicmystical experiences, coupled [...]

Lire la suite

Human psychopharmacology and dose-effects of salvinorin A, a kappa-opioid agonist hallucinogen present in the plant Salvia divinorum, Matthew W. Johnson et al., 2011

Human psychopharmacology and dose-effects of salvinorin A, a kappa-opioid agonist hallucinogen present in the plant Salvia divinorum Matthew W. Johnson, Katherine A. MacLean, Chad J. Reissig, Thomas E. Prisinzano and Roland R. Griffiths Drug and Alcohol Dependence, 2011, 115, (1-2), 150–155. doi: 10.1016/j.drugalcdep.2010.11.005   Abstract Salvinorin A is a potent, selective nonnitrogenous kappa opioid agonist and the known psychoactive constituent of Salvia divinorum, a member of the mint family that has been used for centuries by Mazatec shamans of Mexico for divination and spiritual healing. Salvia divinorum has over the last several years gained increased popularity as a recreational drug. This is a double-blind, placebo controlled [...]

Lire la suite